Ameriprise
OPTN

Ameriprise’s OptiNose OPTN Stock Holding History

Ameriprise’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-10,022
Closed -$675K – 3722
2020
Q1 		$675K Sell
10,022
-90,430
-90% -$9.11M ﹤0.01% 2990
2019
Q4 		$13.9M Sell
100,452
-8,056
-7% -$1.04M 0.01% 1473
2019
Q3 		$11.4M Sell
108,508
-10,215
-9% -$1.02M 0.01% 1597
2019
Q2 		$12.6M Buy
118,723
+15,985
+16% +$2.11M 0.01% 1549
2019
Q1 		$15.9M Buy
102,738
+30,345
+42% +$3.52M 0.01% 1306
2018
Q4 		$6.73M Buy
72,393
+9,560
+15% +$1.37M ﹤0.01% 1915
2018
Q3 		$11.7M Buy
62,833
+25,426
+68% +$7.25M ﹤0.01% 1759
2018
Q2 		$15.7M Buy
37,407
+2,301
+7% +$776K 0.01% 1366
2018
Q1 		$10.5M Buy
35,106
+27,015
+334% +$7.48M ﹤0.01% 1624
2017
Q4 		$2.29M Buy
+8,091
New +$2.28M ﹤0.01% 2587

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Ameriprise's OPTN Position: Q2 2020 in Review

Ameriprise sold out of OptiNose (OPTN) in Q2 2020, closing a stake of 10,022 shares — an estimated $675K sold.

Ameriprise first reported a position in OPTN in Q4 2017 and held it in 10 quarters. The position peaked at $15.9M in Q1 2019. 72 funds tracked by Wall St. Rank hold OPTN as of Q2 2020.

  • Ameriprise reported no remaining OptiNose position as of Q2 2020 after selling out during the quarter.
  • Ameriprise sold 10,022 OptiNose shares in Q2 2020, an estimated $675K.
  • Ameriprise first reported a position in OptiNose in Q4 2017 and held it in 10 quarters.
  • Ameriprise's OptiNose position peaked at $15.9M in Q1 2019.
  • 72 funds tracked by Wall St. Rank held OptiNose as of Q2 2020.

Based on Ameriprise's 13F filing for Q2 2020, filed 14 Aug 2020.